However, the study did not elucidate the mechanism of increased ABCB-1 expression in sunitinib treated cells and used only in vitro model of 786-O cell line, which is of primary ccRCC origin [43]. Here, ABCB1 is linked to nonpapillary renal cell carcinoma.